Cargando…
Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
BACKGROUND: Clostridioides difficile infection (CDI) is a major cause of morbidity among patients with inflammatory bowel disease (IBD). Diagnostic biomarkers for early detection of CDI are needed in clinical practice. The relationship between serum procalcitonin and CDI in IBD patients has not been...
Autores principales: | Abdehagh, Mohammad, Azimirad, Masoumeh, Houri, Hamidreza, Nadalian, Banafsheh, Azimirad, Fahimeh, Olfatifar, Meysam, Nasir Shoeibi, Ome Kolsoum, Yadegar, Abbas, Shahrokh, Shabnam, Mahdavi Roshan, Mehran, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549175/ https://www.ncbi.nlm.nih.gov/pubmed/34702217 http://dx.doi.org/10.1186/s12879-021-06804-2 |
Ejemplares similares
-
Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022) -
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020) -
Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)